Lipid‐based nutrition supplements (LNS) are commonly used to treat moderate acute undernutrition in children. However, existing LNS products mainly focus on providing nutrients and do not address other immediate causes of undernutrition, such as parasitic infection and gut inflammation. Enteric parasites are known to reduce nutrient digestion and absorption, cause chronic gut inflammation, iron deficiency anemia, protein‐energy malnutrition, and reduce growth and cognitive development in children. Oregano essential oil (OEO) is known to have anti‐bacterial and anti‐fungal activity, however its anti‐parasitic properties are poorly understood. This study systemically investigated the effect of OEO and its main bioactive, carvacrol (CV), on prevention of Cryptosporidium parvum infectivity of HCT‐8 (human colon carcinoma) cells in vitro, for potential incorporation of these bioactives into LNS products. HCT‐8 cells were seeded (1 × 106) in 96‐well microtiter plates until confluency (2 days). HCT‐8 cell viability at various concentrations of either OEO or CV was measured using a Live/Dead cell imaging kit. Confluent HCT‐8 cell monolayers were seeded with C. parvum oocytes (1 × 104) in two modalities: 1) 4 h co‐culture of C. parvum oocysts, cells and several dosages (0 μg/mL to 250 μg/mL) of CV or OEO in complete medium, followed by PBS washing and replacement with bioactive‐free media; and 2) 4 h co‐culture of C. parvum oocysts and cells alone, followed by PBS washing and treatment with several dosages (0 μg/mL to 250 μg/mL) of CV or OEO. In either modality, plates were incubated at 37°C and 5% CO2, and after 2‐day incubation, cells and C. parvum were fixed with methanol: acetic acid solution (9:1 v/v). Infectivity was assessed via immunofluorescence detection using C. parvum‐specific antibody staining (Sporo‐Glo™) and phase contrast/fluorescent microscopy. Deformation of cell monolayers and loss of cell viability was found at 50 μg/mL CV, whereas no loss in cell viability was observed in cells treated with OEO at dosages as high as 125 μg/mL (containing similar concentrations of CV). In modality 1 experiments, cells simultaneously treated with C. parvum and various dosages of OEO or CV presented similar amounts of infection after 4 h incubation as those cells treated with C. parvum alone. In modality 2 experiments, after 2‐day treatment with bioactives, a 50% reduction in C. parvum infectivity was observed at 25 μg/mL of CV and at 125 μg/mL of OEO. C. parvum is one of the most resilient enteric parasites and prevalent in most of the developing world. Incorporation of OEO or CV into LNS formulas may provide double benefit to at risk populations afflicted by undernutrition and gut infection living in low‐income settings.Support or Funding InformationIndian Council of Agricultural Research (ICAR), India